| Dr Thomas Joseph Raimondo, | |
|
1050 Warwick Ave, Warwick, RI 02888-3655 | |
| (401) 467-6257 | |
| (401) 785-1191 |
| Full Name | Dr Thomas Joseph Raimondo |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 39 Years |
| Location | 1050 Warwick Ave, Warwick, Rhode Island |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245236918 | NPI | - | NPPES |
| 9003083 | Medicaid | RI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | DO00347 (Rhode Island) | Primary |
| 2084N0400X | Psychiatry & Neurology - Neurology | DO00347 (Rhode Island) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Roger Williams Medical Center | Providence, RI | Hospital |
| Kent County Memorial Hospital | Warwick, RI | Hospital |
| Women & Infants Hospital Of Rhode Island | Providence, RI | Hospital |
| The Miriam Hospital | Providence, RI | Hospital |
| South County Hospital Inc | Wakefield, RI | Hospital |
| Entity Name | Kent County Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386643294 PECOS PAC ID: 2668377078 Enrollment ID: O20041115000704 |
News Archive
SunLink Health Systems, Inc. today announced earnings from continuing operations for its fourth fiscal quarter ended June 30, 2009 of $850,000, or $0.11 per fully diluted share, compared to earnings from continuing operations of $579,000, or $0.07 per fully diluted share, for the quarter ended June 30, 2009.
To help provide a streamlined system for disposing of hazardous pharmaceutical waste that is protective of public health and the environment, the U.S. Environmental Protection Agency is proposing to add hazardous pharmaceutical waste to the Universal Waste Rule.
A newly-published assessment of health facilities in Lebanon shows that a quarter of those examined are not functioning due to physical damage, lack of staff or lack of accessibility, and that water and fuel shortages remain a serious concern.
China Aoxing Pharmaceutical Company, Inc. (OTCBB: CAXG) ("China Aoxing"), a China-based pharmaceutical company specializing in research, development, manufacturing and distribution of narcotic and pain-management products, today announced that its Clinical Trial Application ("CTA") for Tilidine/Naloxone Capsules, an opioid drug with abuse resistance property, was officially approved by the China State Food and Drug Administration ("SFDA").
Researchers have found a potential new target for treating asthma, according to a study led by researchers at the University of Colorado School of Medicine at the Anschutz Medical Campus and published in the journal Nature Communications.
› Verified 9 days ago
| Entity Name | The Medical Group Of Rhode Island, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033193925 PECOS PAC ID: 4981620945 Enrollment ID: O20051019000178 |
News Archive
SunLink Health Systems, Inc. today announced earnings from continuing operations for its fourth fiscal quarter ended June 30, 2009 of $850,000, or $0.11 per fully diluted share, compared to earnings from continuing operations of $579,000, or $0.07 per fully diluted share, for the quarter ended June 30, 2009.
To help provide a streamlined system for disposing of hazardous pharmaceutical waste that is protective of public health and the environment, the U.S. Environmental Protection Agency is proposing to add hazardous pharmaceutical waste to the Universal Waste Rule.
A newly-published assessment of health facilities in Lebanon shows that a quarter of those examined are not functioning due to physical damage, lack of staff or lack of accessibility, and that water and fuel shortages remain a serious concern.
China Aoxing Pharmaceutical Company, Inc. (OTCBB: CAXG) ("China Aoxing"), a China-based pharmaceutical company specializing in research, development, manufacturing and distribution of narcotic and pain-management products, today announced that its Clinical Trial Application ("CTA") for Tilidine/Naloxone Capsules, an opioid drug with abuse resistance property, was officially approved by the China State Food and Drug Administration ("SFDA").
Researchers have found a potential new target for treating asthma, according to a study led by researchers at the University of Colorado School of Medicine at the Anschutz Medical Campus and published in the journal Nature Communications.
› Verified 9 days ago
| Entity Name | Thomas Raimondo Do, Ltd |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710517099 PECOS PAC ID: 2264863018 Enrollment ID: O20200511001505 |
News Archive
SunLink Health Systems, Inc. today announced earnings from continuing operations for its fourth fiscal quarter ended June 30, 2009 of $850,000, or $0.11 per fully diluted share, compared to earnings from continuing operations of $579,000, or $0.07 per fully diluted share, for the quarter ended June 30, 2009.
To help provide a streamlined system for disposing of hazardous pharmaceutical waste that is protective of public health and the environment, the U.S. Environmental Protection Agency is proposing to add hazardous pharmaceutical waste to the Universal Waste Rule.
A newly-published assessment of health facilities in Lebanon shows that a quarter of those examined are not functioning due to physical damage, lack of staff or lack of accessibility, and that water and fuel shortages remain a serious concern.
China Aoxing Pharmaceutical Company, Inc. (OTCBB: CAXG) ("China Aoxing"), a China-based pharmaceutical company specializing in research, development, manufacturing and distribution of narcotic and pain-management products, today announced that its Clinical Trial Application ("CTA") for Tilidine/Naloxone Capsules, an opioid drug with abuse resistance property, was officially approved by the China State Food and Drug Administration ("SFDA").
Researchers have found a potential new target for treating asthma, according to a study led by researchers at the University of Colorado School of Medicine at the Anschutz Medical Campus and published in the journal Nature Communications.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Thomas Joseph Raimondo, 1050 Warwick Ave, Warwick, RI 02888-3655 Ph: (401) 467-6257 | Dr Thomas Joseph Raimondo, 1050 Warwick Ave, Warwick, RI 02888-3655 Ph: (401) 467-6257 |
News Archive
SunLink Health Systems, Inc. today announced earnings from continuing operations for its fourth fiscal quarter ended June 30, 2009 of $850,000, or $0.11 per fully diluted share, compared to earnings from continuing operations of $579,000, or $0.07 per fully diluted share, for the quarter ended June 30, 2009.
To help provide a streamlined system for disposing of hazardous pharmaceutical waste that is protective of public health and the environment, the U.S. Environmental Protection Agency is proposing to add hazardous pharmaceutical waste to the Universal Waste Rule.
A newly-published assessment of health facilities in Lebanon shows that a quarter of those examined are not functioning due to physical damage, lack of staff or lack of accessibility, and that water and fuel shortages remain a serious concern.
China Aoxing Pharmaceutical Company, Inc. (OTCBB: CAXG) ("China Aoxing"), a China-based pharmaceutical company specializing in research, development, manufacturing and distribution of narcotic and pain-management products, today announced that its Clinical Trial Application ("CTA") for Tilidine/Naloxone Capsules, an opioid drug with abuse resistance property, was officially approved by the China State Food and Drug Administration ("SFDA").
Researchers have found a potential new target for treating asthma, according to a study led by researchers at the University of Colorado School of Medicine at the Anschutz Medical Campus and published in the journal Nature Communications.
› Verified 9 days ago
Dr. Sterling Leaf Malish, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 455 Toll Gate Rd, Warwick, RI 02886 Phone: 401-737-7000 | |
Dr. John David Lowney, Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1030 Warwick Ave, Warwick, RI 02888 Phone: 401-467-6257 Fax: 401-785-1191 | |
Dr. Christian Rene Herard, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 300 Tollgate Road, Suite 302, Warwick, RI 02886 Phone: 401-738-4014 Fax: 401-738-4090 | |
John A Gelzhiser, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 455 Toll Gate Rd, Warwick, RI 02886 Phone: 401-737-7000 Fax: 401-736-4265 | |
Dr. Michael Seidler, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 125 Metro Center Blvd Ste 2000, Warwick, RI 02886 Phone: 401-921-9202 Fax: 401-921-9212 | |
Murli K Raman, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 455 Tollgate Rd, Brigham & Women's Cardiovascular Associates At Cne, Warwick, RI 02886 Phone: 401-681-4996 Fax: 401-921-6569 | |
Dr. Jennifer F Jarbeau, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 400 Bald Hill Rd Ste 524, Warwick, RI 02886 Phone: 401-737-7313 Fax: 401-737-4207 |